Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MIR7113 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TPP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDIP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C9orf64 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC729652 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
RDH13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
DHX40 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MGST3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NOX1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ABHD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UNC93A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100506113 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDK13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM26-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CACNA1E - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC34A3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATPIF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on